Market Report for PET Imaging in the USA

April 2016 | 139 pages | ID: M9B57F5F294EN
Black Swan Analysis limited

Abstracts

Market Report for PET Imaging in the USA

This report provides information on the current Positron Emission Tomography (PET) scanner and cyclotron install base in the USA market. Along with the current known number of PET scanners and cyclotrons in the USA, the report also contains a detailed breakdown of this equipment by year of installation, manufacturer, model, specific location and current utilization. The future market utility for the PET scanner and cyclotron market is also estimated to the year 2020.

PET as a modality was introduced into the US market in the early 1980s, but it was not until 1995 when a PET scanner was able to perform a whole body scan that the utility in oncology was realised. The appeal of PET imaging to radiologists and nuclear medics is its ability to provide metabolic information that can be overlaid with a structural CT scan. This makes it the standard of care for staging any patient that has been diagnosed with cancer. This adoption of technology by clinicians has contributed to the establishment and continued growth in the USA in the number of PET scanners and cyclotrons producing the widely used 18F – FDG radiotracer.

Providing a value-added level of insight from the analysis team at Black Swan, an introduction on PET imaging is given, as well as information on:

• The utilization of PET and the development of the PET modality over time in the USA market
• Current USA healthcare system and reimbursement for PET imaging
• Market evolution and future developments

This report is built using a combination of data and information sourced from the expertise within the Black Swan Analysis team, customer surveys, equipment manufacturer surveys and an audit of FDA approved PET scanners and F18 radio-isotope cyclotron manufacturing sites.

Reason to buy

• A helpful aid in gauging the imaging capacity for future treatments, such as in the case of Alzheimer’s disease, where patients will require a PET scan prior to the start of treatment
• Deliver a realistic study sizing plan for any clinical trial that requires patients to have a PET scan prior to treatment
• Gain an understanding of the current players in the PET scanner and cyclotron markets
• Gain further insight into the evolution of PET scanners and cyclotrons over time
• Provide a level of understanding on current National PET scanner provision and the potential headroom and market capacity for future utilization
• Identify specific locations in the USA that currently has a PET scanner or cyclotron
• Delivery of detailed information on year of installation, manufacturer and model type of specific PET scanners and cyclotrons
• Insight into the different therapeutic areas, such as oncology, that utilize PET scanners
• Information regarding the development of new tracers and future PET technology

Contents

Glossary of Terms
USA Market Summary
Introduction to PET
  What is PET Imaging?
  How are PET radiopharmaceuticals manufactured?
  How is PET Imaging Used?
    Oncology
    Cardiology
    Neurology
USA
  Introduction
    Health Care System in the USA
  Development of PET
    History of PET
    PET Activity in the USA
  Reimbursement
  Current provision
    Cyclotrons
    PET Market
    Static PET Scanners
  Utilization of PET
  Market Evolution
    Cyclotrons & PET Scanners
    USA Research & PET Scanning
    Additional Developments in the US Market
  PET Demand and Provision Forecast
Future Developments in the PET Market
  Cyclotrons & Manufacturing
  PET Scanning Technology
  Development of New Tracers
    Oncology
    Cardiology
    Neurology
Methodology
Potential Sources of Error
References
APPENDIX

List Of Figures

LIST OF FIGURES

Number of scanners per million population by State in the USA
Cyclotrons by main ownership type, USA
Cyclotrons by FDA registration status, USA
Installed cyclotrons by manufacturer, USA
Cyclotrons per PET scanner by State in the USA
Number of PET scanners by type, USA
Number of PET Scanners by Manufacturer, USA
Static and mobile, known PET market, USA
Map of PET radiopharmacies in the USA
Total number of PET scanners by state
Number of static PET scanners by manufacturer, USA
Static PET machines by type, USA
Static PET machines by type, USA
Utilisation of PET imaging by therapeutic area, USA
Utilisation of PET imaging within oncology, USA
Estimated historical capacity for the provision of PET scan procedures, USA
Potential market capacity and the expected head room in the market for PET scan procedures, USA
Estimated future provision of PET scanners and cyclotrons, USA
Composition of the PET scanning market 2015 & 202, USA
Estimated future capacity for the provision of PET scan procedures, USA

List Of Tables

LIST OF TABLES

Half-life of commonly used positron emitters
Key Facts USA
Installation of new cyclotrons in the USA since 2005 by network or affiliation
Known installations of cyclotrons over the next 5 years, USA
Static PET static scanner installation by manufacturer type over a 7 year period, USA
USA PET scans 2010-2015
Annual scanning capacity of different PET machines and PET hybrids
Assumptions on the estimated number of doses produced by cyclotrons per annum
Locations of PET cyclotrons in the USA
Locations of PET scanners in the USA